AcuCort
PublicAcuCort is now publicly traded
The data on this page reflects AcuCort's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Apr 24, 2017
Last Round
Follow-on Offering
Feb 3, 2025
Total Funding Raised
$17.55M
Company Overview
AcuCort is based in Lund. It has raised $17.55M.
AcuCort AB is a Swedish pharmaceutical company that develops and commercializes innovative drugs for patients. The company's primary product is Zeqmelit®, a fast-dissolving oral film containing the well-known substance dexamethasone. Zeqmelit® is designed for user-friendly and rapid relief in acute situations such as severe allergic reactions, croup in children, and chemotherapy-induced nausea and vomiting. The drug is approved in Sweden, Denmark, Norway, and Finland. AcuCort's business model focuses on commercializing its products through a global network of licensees and distributors. The company was founded in 2006 and is publicly listed on the Spotlight Stock Market in Sweden under the ticker ACUC.
AI Layer
Non-AI
AcuCort Comparables
Compare AcuCort with similar companies based on industry and business-model similarity.
No comparables are published for AcuCort. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
AcuCort Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Feb 3, 2025 | ||||
| Private Placement | Mar 26, 2024 | ||||
| Follow-on Offering | Oct 31, 2023 | ||||
| Follow-on Offering | Nov 8, 2021 | ||||
| Follow-on Offering | Sep 5, 2019 | ||||
Follow-on Offering | Oct 10, 2018 |
For institutional investors. Book with your work email.
AcuCort Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Life Science Invest Fund 1 | Follow-on Offering, Private Placement |
AcuCort Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.